ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
7 580,88
-0,68%
Dow Jones
40 211,72
0,53%
DAX
18 495,22
-0,56%
Brent Oil
83,655
-0,81%
Bitcoin
62 730,99
-3,27%
Registration Strip Icon for discussion Inscrivez-vous pour interagir sur nos forums actifs pour discuter avec des investisseurs aux idées similaires.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ
  6. Constellation Pharmaceuticals Inc (CNST)

  7. Constellation Pharmaceuticals Inc (CNST) Actualités

CNST

Constellation Pharmaceut... (CNST)

Constellation Pharmaceuticals Inc
De:
Trier par:
 Showing the most relevant articles for your search:NASDAQ:CNST
DateHeureSourceTitreSymboleSociété
16/05/201915h00GlobeNewswire Inc.Constellation Pharmaceuticals Provides Interim Update of Data for CPI-0610 in ASCO and EHA AbstractsNASDAQ:CNSTConstellation Pharmaceuticals Inc
15/05/201923h27Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:CNSTConstellation Pharmaceuticals Inc
08/05/201922h40Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:CNSTConstellation Pharmaceuticals Inc
08/05/201922h15GlobeNewswire Inc.Constellation Pharmaceuticals Announces First-Quarter 2019 Financial ResultsNASDAQ:CNSTConstellation Pharmaceuticals Inc
26/04/201913h16Edgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (defa14a)NASDAQ:CNSTConstellation Pharmaceuticals Inc
26/04/201913h13Edgar (US Regulatory)Proxy Statement (definitive) (def 14a)NASDAQ:CNSTConstellation Pharmaceuticals Inc
19/04/201914h00GlobeNewswire Inc.Constellation Pharmaceuticals to Present at the Solebury Trout Class of 2018 Biotech IPOs Investor DayNASDAQ:CNSTConstellation Pharmaceuticals Inc
09/04/201914h55GlobeNewswire Inc.Report: Exploring Fundamental Drivers Behind The Cooper Companies, Encompass Health, SilverCrest Metals, Constellation Pharma...NASDAQ:CNSTConstellation Pharmaceuticals Inc
01/04/201919h00GlobeNewswire Inc.Constellation Pharmaceuticals Presents Results from Phase 1b Portion of ProSTAR Clinical Trial of CPI-1205 at AACR MeetingNASDAQ:CNSTConstellation Pharmaceuticals Inc
15/03/201911h25Edgar (US Regulatory)Securities Registration: Employee Benefit Plan (s-8)NASDAQ:CNSTConstellation Pharmaceuticals Inc
14/03/201922h25Edgar (US Regulatory)Annual Report (10-k)NASDAQ:CNSTConstellation Pharmaceuticals Inc
14/03/201922h24GlobeNewswire Inc.Constellation Pharmaceuticals Announces Fourth-Quarter and Full-Year 2018 Financial ResultsNASDAQ:CNSTConstellation Pharmaceuticals Inc
13/03/201921h20Edgar (US Regulatory)Amended Current Report Filing (8-k/a)NASDAQ:CNSTConstellation Pharmaceuticals Inc
08/03/201922h56Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:CNSTConstellation Pharmaceuticals Inc
06/03/201920h35GlobeNewswire Inc.Constellation Pharmaceuticals to Present at Upcoming Investor ConferenceNASDAQ:CNSTConstellation Pharmaceuticals Inc
04/03/201913h00GlobeNewswire Inc.Constellation Pharmaceuticals Appoints Jessica Christo as Chief Product Development OfficerNASDAQ:CNSTConstellation Pharmaceuticals Inc
22/02/201919h24GlobeNewswire Inc.Constellation Pharmaceuticals to Present at Upcoming Investor ConferencesNASDAQ:CNSTConstellation Pharmaceuticals Inc
21/02/201900h45Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)NASDAQ:CNSTConstellation Pharmaceuticals Inc
20/02/201913h00GlobeNewswire Inc.Constellation Pharmaceuticals Announces Appointment to Board of DirectorsNASDAQ:CNSTConstellation Pharmaceuticals Inc
14/02/201922h17Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:CNSTConstellation Pharmaceuticals Inc
13/02/201922h49Edgar (US Regulatory)Statement of Ownership (sc 13g)NASDAQ:CNSTConstellation Pharmaceuticals Inc
03/01/201913h00GlobeNewswire Inc.Constellation Pharmaceuticals Provides Update on MANIFEST Clinical Trial of CPI-0610 in Myelofibrosis, Reviews 2018 Accomplis...NASDAQ:CNSTConstellation Pharmaceuticals Inc
20/12/201819h34GlobeNewswire Inc.Constellation Pharmaceuticals to Present at J.P. Morgan Healthcare ConferenceNASDAQ:CNSTConstellation Pharmaceuticals Inc
10/12/201822h49GlobeNewswire Inc.Constellation Pharmaceuticals Initiates Phase 2 Portion of ProSTAR Clinical Trial in Patients with Metastatic Castration-Resi...NASDAQ:CNSTConstellation Pharmaceuticals Inc
29/11/201820h00GlobeNewswire Inc.Constellation Pharmaceuticals to Present at BMO Healthcare ConferenceNASDAQ:CNSTConstellation Pharmaceuticals Inc
29/11/201815h22GlobeNewswire Inc.Constellation Pharmaceuticals Appoints Patrick Trojer, Ph.D., as Chief Scientific OfficerNASDAQ:CNSTConstellation Pharmaceuticals Inc
15/11/201813h00GlobeNewswire Inc.Constellation Pharmaceuticals Highlights EZH2 Inhibition Program in Prostate Cancer at Biomedical ConferenceNASDAQ:CNSTConstellation Pharmaceuticals Inc
08/11/201822h30GlobeNewswire Inc.Constellation Pharmaceuticals Announces Third-Quarter and Nine-Month 2018 Financial ResultsNASDAQ:CNSTConstellation Pharmaceuticals Inc
01/11/201812h00GlobeNewswire Inc.Constellation Pharmaceuticals Receives FDA Fast Track Designation for CPI-0610 in Treatment of MyelofibrosisNASDAQ:CNSTConstellation Pharmaceuticals Inc
10/10/201822h30GlobeNewswire Inc.Constellation Pharmaceuticals Enhances and Expands Phase 2 MANIFEST Study of CPI-0610 in MyelofibrosisNASDAQ:CNSTConstellation Pharmaceuticals Inc
 Showing the most relevant articles for your search:NASDAQ:CNST

Dernières Valeurs Consultées

BIT
P257C7
NLBNPIT257C7 20351221 35...
BIT
P1AKG7
BNP Paribas Issuance
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

France
Société
Entreprise
Popular
Obtenir l'application
App Store
Google Play

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés